Disease: Hemolytic-uremic syndrome
- <em>Bifidobacterium longum</em> K5 Prevents Enterohaemorrhagic <em>Escherichia coli</em> O157:H7 Infection in Mice through the Modulation of the Gut Microbiota
- A 26-year-old man with multiple organ failure caused by <em>Aeromonas dhakensis</em> infection: a case report and literature review
- A 6-year retrospective study of clinical features, microbiology, and genomics of Shiga toxin-producing <em>Escherichia coli</em> in children who presented to a tertiary referral hospital in Costa Rica
- A Case of Atypical Hemolytic Uremic Syndrome Triggered by Acute Pancreatitis in a Patient with a Membrane Cofactor Protein (CD46) Genetic Variant
- A case of hypertensive emergency with alveolar hemorrhage and thrombotic microangiopathy
- A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy
- A colorimetric and SERS dual-mode aptasensor for the detection of Shiga toxin type II based on Mn/Fe-MIL(53)@AuNSs
- A pediatric case of atypical hemolytic uremic syndrome (aHUS): Could any infection play a triggering role?
- A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti-Shiga toxin hyperimmune equine F (ab')<sub>2</sub> fragments in healthy volunteers
- A Rare Case of Autoimmune Disorder as a Trigger for Atypical Hemolytic Uremic Syndrome
- A Successful Approach to Diagnosing Shiga-like Toxin-Producing <em>Escherichia coli</em>-Induced Colitis
- Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome
- Adolescence-onset atypical hemolytic uremic syndrome: is it different from infant-onset?
- ANCA-Associated Vasculitis with Systemic Thrombotic Microangiopathy: A Review of Literature
- Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
- Anti-factor B antibodies in atypical hemolytic uremic syndrome
- Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies
- Assessment of South Asian Pediatric Acute Kidney Injury: Epidemiology and Risk Factors (ASPIRE)-a prospective study on "severe dialysis dependent pediatric AKI"
- Atypical hemolytic uremic syndrome in a child: A rare case report
- Atypical Hemolytic Uremic Syndrome: A Nationwide Colombian Pediatric Series
- Authors' Reply: Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic Uremic Syndrome
- Autonomic activity and cardiovascular system risk assessment in pediatric patients with hemolytic uremic syndrome
- Bilateral Retinal Venous Occlusion in Atypical Hemolytic-Uremic Syndrome Due to Complement Factor H Mutation
- Breastfeeding and hemolytic uremic syndrome
- Cardiac Manifestation in a Child With Atypical Hemolytic Uremic Syndrome
- Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication
- Characteristics of hemolytic uremic syndrome in patients from a pediatric hospital in Peru, 2010-2020
- Cobalamin C Deficiency: An Uncommon Cause of Hemolytic Uremic Syndrome
- Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy
- Complete genome sequence of eight LEE-negative Shiga toxin-producing Escherichia coli strains isolated from patients with hemolytic-uremic syndrome
- Design of a novel multi-epitopes vaccine against <em>Escherichia fergusonii</em>: a pan-proteome based <em>in- silico</em> approach
- Detection of Cleaved Stx2a in the Blood of STEC-Infected Patients
- Developing International Classification of Disease code definitions for the study of enteric infection sequelae in Canada
- Development of a Rapid and Sensitive CANARY Biosensor Assay for the Detection of Shiga Toxin 2 from <em>Escherichia coli</em>
- Diagnostic Challenges and Emerging Pathogeneses of Selected Glomerulopathies
- Different populations of A(H1N1)pdm09 viruses in a patient with hemolytic-uremic syndrome
- Diffuse alveolar haemorrhage due to atypical hemolytic uremic syndrome (aHUS) associated with COVID-19
- Do asymptomatic STEC-long-term carriers need to be isolated or decolonized? New evidence from a community case study and concepts in favor of an individualized strategy
- Dynamic evolution of kidney function in patients with STEC-hemolytic uremic syndrome followed for more than 15 years: unexpected changes
- Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics
- Eculizumab for pregnancy-related atypical hemolytic uremic syndrome
- Eculizumab in severe Shiga toxin-mediated haemolytic uraemic syndrome
- Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic-Uremic Syndrome
- Effect of Ground Beef Irradiation on Annual Nontyphoidal Salmonella and Escherichia coli O157 Burden and Direct Healthcare Costs in the United States: A Simulation Study
- Effects of Metabolites of Lactobacillus casei on Expression and Neutralization of Shiga Toxin by Enterohemorrhagic Escherichia coli
- Efficacy and Safety of Eculizumab in Enteroaggregative <em>E. coli</em> Associated Hemolytic Uremic Syndrome
- Efficacy and Safety of Eculizumab in Enteroaggregative E. coli Associated Hemolytic Uremic Syndrome
- Epidemiology, Management, and Outcome of Atypical Hemolytic Uremic Syndrome in an Omani Cohort
- Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study
- Gastrointestinal involvement in STEC-associated hemolytic uremic syndrome: 10 years in a pediatric center
- Genetic Characterization of Intimin Gene (<em>eae</em>) in Clinical Shiga Toxin-Producing <em>Escherichia coli</em> Strains from Pediatric Patients in Finland
- Genomic island-encoded regulatory proteins in enterohemorrhagic <em>Escherichia coli</em> O157:H7
- Genomic surveillance of STEC/EHEC infections in Germany 2020 to 2022 permits insight into virulence gene profiles and novel O-antigen gene clusters
- HELLP Syndrome and Differential Diagnosis with Other Thrombotic Microangiopathies in Pregnancy
- Hemolytic Uremic Syndrome
- Hemolytic uremic syndrome as a rare complication in a case of Castleman disease
- HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies
- Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome
- Infection and antibiotic-associated changes in the fecal microbiota of <em>C. rodentium</em> Ď•<em>stx2<sub>dact</sub></em>-infected C57BL/6 mice
- Management of pediatric hemolytic uremic syndrome
- Managing anti-factor H antibody-associated hemolytic uremic syndrome: time for consensus
- Molecular detection and antibiogram of Shiga toxin-producing <em>Escherichia coli</em> (STEC) from raw milk in and around Bahir Dar town dairy farms, Ethiopia
- Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome
- Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up
- Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition
- Pregnancy as a susceptible state for thrombotic microangiopathies
- Pregnancy-Associated Atypical Hemolytic Uremic Syndrome Successfully Treated with Ravulizumab: A Case Report
- Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report with MCP Gene Mutation and Successful Eculizumab Treatment
- Prevalence and Characteristics of Plasmid-Encoded Serine Protease EspP in Clinical Shiga Toxin-Producing <em>Escherichia coli</em> Strains from Patients in Sweden
- Public health risks of raw milk consumption: Lessons from a case of paediatric hemolytic uremic syndrome
- Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
- Ravulizumab facilitates reduced burden of vascular access, a major benefit in paediatric atypical haemolytic uraemic syndrome
- Recurrent disease after pediatric renal transplantation
- Red blood cell-derived arginase release in hemolytic uremic syndrome
- Regulation of human neutrophil IL-1beta secretion induced by Escherichia coli O157:H7 responsible for hemolytic uremic syndrome
- Retraction: Novel Variation in CFB Adult Onset Atypical Hemolytic Uremic Syndrome: A Case Report and Review
- Risk of Streptococcus pneumoniae-associated haemolytic uraemic syndrome in industrialised nations: a systematic review of the literature
- RpoS acts as a global repressor of virulence gene expression in E. coli O104:H4 and enteroaggregative E. coli
- Schistocyte detection in artificial intelligence age
- Seizure as First Manifestation of Hemolytic Uremic Syndrome with Bacteremia due to Shiga Toxin-Producing Escherichia coli
- Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy
- Severe hemolysis, elevated liver enzymes, and low platelet syndrome requiring differentiation of thrombotic microangiopathy: Four cases from a nationwide survey in Japan
- Shiga Toxin-Producing <em>Escherichia coli</em> Testing in New York 2011-2022 Reveals Increase in Non-O157 Identifications
- Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome
- Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome. Reply
- Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia
- Shiga Toxin‒Producing Escherichia coli Diagnoses from Health Practitioners, Queensland, Australia
- STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report
- Structure-Function Analysis of the A1 Subunit of Shiga Toxin 2 with Peptides That Target the P-Stalk Binding Site and Inhibit Activity
- Successful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused by the heterozygous deletion of CFH in a patient with end-stage kidney disease of uncertain etiology
- Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature
- The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older
- The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome
- The unanswered question. When to undertake a maternity journey?
- Therapeutic apheresis: is it safe in children with kidney disease?
- Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review
- Transcription levels of hes and their involvement in the biofilm formation of Shiga toxin-producing Escherichia coli O91
- Various phenotypes of postpartum atypical hemolytic uremic syndrome: the role of genetic testing in determining prognosis. Case report
- Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children
- What came first, atypical hemolytic uremic syndrome or malignant hypertension: a clinical dilemma